Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3
Submit an article Journal homepage
69
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Valproic acid rechallenge after valproate-induced hyperammonemic encephalopathy

Farhan MithaniCollege of Medicine, Texas A&M Health Science Center, Bryan, Texas; ;Department of Psychiatry, Houston Methodist Hospital, Houston, TexasCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2826-3430
, BSORCID Icon,
Stav CullumCollege of Medicine, Texas A&M Health Science Center, Bryan, Texas; ;Department of Psychiatry, Houston Methodist Hospital, Houston, TexasORCID Iconhttp://orcid.org/0000-0003-0160-3578
, BSORCID Icon &
Ranjit ChackoDepartment of Psychiatry, Houston Methodist Hospital, Houston, TexasORCID Iconhttp://orcid.org/0000-0002-4359-2312
, MDORCID Icon
Pages 471-472 | Received 01 Apr 2020, Accepted 07 May 2020, Published online: 21 May 2020

  • Romana JS, Villalba R. Valproic acid and hyperammonemia in a patient with bipolar disorder. Biol Psychiatry. 1998;43(8):1–6.
  • Sattar Y, Merotto B, Dedousis A, Aadil M, Zil-E-Ali A. Valproic acid-induced hyperammonemia with encephalopathy (VIHE): a case report. J Med Res Innov. 2018;2(1):e000108–170.
  • Brown LM, Cupples N, Moore TA. Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: a case series and literature review. Ment Health Clin. 2018;8(3):148–154.
  • Nakamura M, Nagamine T. The effect of carnitine supplementation on hyperammonemia and carnitine deficiency treated with valproic acid in a psychiatric setting. Innov Clin Neurosci. 2015;12(9-10):18–24.
  • Sattar Y, Wasiq S, Yasin W, Khan AM. Carglumic acid treatment of a patient with recurrent valproic acid-induced hyperammonemia: a rare case report. Cureus. 2018;10(9):234–251.
  • Baddour E, Tewksbury A, Stauner N. Valproic acid-induced hyperammonemia: incidence, clinical significance, and treatment management. Ment Health Clin. 2018;8(2):73–77.
  • Chopra A, Kolla BP, Mansukhani MP, et al. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry. 2012;34(3):290–298.
  • Dealberto MJ. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol. 2007;22(6):330–337.
  • Pradeep RJ. Valproate monotherapy induced-delirium due to hyperammonemia: A report of three adult cases with different types of presentation. Indian J Psychiatry. 2008;50(2):121–123.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.